Albert Bourla

Chief Executive Officer at Pfizer, Inc.

Albert Bourla

Albert Bourla

Chief Executive Officer at Pfizer, Inc.

Biography

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Previously, from February 2016 to December 2017, Albert served as Group President of

Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010-2013, leading the development and implementation of strategies and tactics related to Pfizer’s off-patent portfolio, (including legacy brands and generics.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001. From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001-2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of The Partnership for New York City, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.

Overview
Career Highlights

Pfizer, Inc.

RelSci Relationships

6599

Number of Boards

9

Birthday

1962

Age

59

Contact Data
Trying to get in touch with Albert Bourla? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Albert Bourla likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Population Health Investment Co., Inc.

Relationship likelihood: Strong

Group President, Chief Business Officer at Pfizer, Inc.

Relationship likelihood: Strong

Chief Scientific Officer & President, Worldwide Research, Development & Medical at Pfizer, Inc.

Relationship likelihood: Strong

Chief Corporate Affairs Officer & Executive Vice President at Pfizer, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Pfizer, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Rabin Martin

Relationship likelihood: Strong

Executive Director at Pfizer, Inc.

Relationship likelihood: Strong

Assistant General Counsel & Assistant Secretary in the Corporate Governance Group, Legal Division at Pfizer, Inc.

Relationship likelihood: Strong

Group President, Pfizer BioPharmaceuticals Group at Pfizer, Inc.

Relationship likelihood: Strong

Senior Director, Worldwide Safety & Regulatory at Pfizer, Inc.

Relationship likelihood: Strong

Paths to Albert Bourla
Potential Connections via
Relationship Science
You
Albert Bourla
Chief Executive Officer at Pfizer, Inc.
Education
Memberships
Member
Current

The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC.

Member
Current

The Business Council is a voluntary association of business leaders whose members meet several times a year for the free exchange of ideas both among themselves and with thought leaders from many sectors. In its most fundamental form, the Council seeks to foster understanding through discussion. It promotes learning, best practice sharing and networking by its members with a view to making a contribution to our society, the global economy and to business generally. Since its founding more than 75 years ago, The Business Council membership has consisted of a group of current or former chief executive officers from a broad range of companies. All major industries are represented among the members of The Business Council. Because schedule demands on senior business executives are extensive, the Council provides an especially valuable opportunity to discuss major subjects in a broader ranging forum than is normally available in the course of business activities. As part of its process, the Council invites leaders in government, politics, academia, science, medicine, technology and other sectors to address the Council and to participate in its discussions. Council members hope that these discussions result in better understanding by their invited guests as well as by the members themselves. Today, the Council meets three times a year in a collegial atmosphere to share and explore ideas.As a gathering of peers from many fields, the Council is entirely an educational and deliberative forum. It never takes positions as an organization and does not advocate any policy or course of action. Individual members sometimes do present their own views in public discussions. But they do so as individuals, rather than as representatives of the Council.

Member
Current

CEO Action For Diversity & Inclusion is the CEO-driven business commitment to advance diversity and inclusion within the workplace. The company is headquartered in Chicago, IL.

Career History
Chief Executive Officer
2001 - Current

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Technical Director, Animal Health Division
1993 - Prior
Political Donations
$208
2017
$208
2017
$208
2017
Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
2018 World Economic Forum Annual Meeting

Other Affiliations

Albert Bourla is affiliated with Pfizer, Inc., Pfizer Hellas AE

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Albert Bourla. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Albert Bourla's profile does not indicate a business or promotional relationship of any kind between RelSci and Albert Bourla.